Newsroom
New Guiding Principles for Patient-Centered Care
Patient-centered care has been getting a lot of attention as the healthcare industry focuses on the Triple Aim of delivering better health outcomes, improving patient experience, and reducing the cost of care. In that vein, the Louis W. Sullivan Institute for Healthcare Innovation recently released 6 guiding principles of patient-centered care.
Financial, Clinical Outcomes for Hospitals Converting to For-Profit Status
Converting to for-profit status has a positive influence on a hospital’s finances, but no effect on quality or mortality rates, found researchers from the Harvard School of Public Health and Brigham and Women’s Hospital.
Collaborative Model Succeeds in Reducing Cancer Patient Readmissions
Oncologists and palliative care specialists at Duke University Hospital worked together in patient care, resulting in a 23% reduction in patient readmission within a week of discharge.
Hospitals’ Struggles to Beat Back Familiar Infections Began Before Ebola Arrived
While Ebola stokes public anxiety, more than 1 in six hospitals—including some top medical centers—are having trouble stamping out less exotic but sometimes deadly infections, federal records show.
In the Literature: A Speech Gene Prevents Breast Cancer Metastasis
The study, published in Cell Stem Cell, identified a microRNA-mediated inhibitory pathway that repressed expression of the speech and language gene FOXP2, promoting metastases of breast cancer cells to distant sites.
Plans Place Spending Caps to Reduce Costs
While reference pricing helps contain costs for insurers, it pits patients between the payer and provider.
Everolimus Under FDA Scrutiny For Potential Risk
Everolimus has been added to FDA's Adverse Event Reporting System due to a possible risk of hypertension.
Quality of Care Takes Precedence for Breast Cancer Patients in New Jersey
Horizon BCBS partners with RCCA to improve quality of care for breast cancer patients by evaluating their molecular subtype before administering treatment.
Impacts on Premiums, Enrollment If the ACA Is Modified
Ending the subsidies offered under the Affordable Care Act would sharply increase costs for consumers, according to a study from the RAND Corporation. Furthermore, without the subsidies, more than 11 million Americans will lose their health insurance.
Nanotechnology Can Aid Early Cancer Diagnosis
This novel fluorescent imaging technique uses shortwave IR, which has much better tissue penetration than near-IR currently used in imaging.
Healthy Competition Can Reduce Healthcare Costs
The study, published in JAMA, evaluates the impact of the a decrease in single-physician practices as doctors prefer to join larger healthcare organizations.
The Commonwealth Fund Launches A Healthcare Quality Measurement Tool
WhyNotTheBest.org maintained by The Commonwealth Fund is a free resource for healthcare professionals interested in tracking performance on various measures of healthcare quality.
Nine in 10 Uninsured Don’t Know When Open Enrollment Begins
Congressional candidates may be still be talking about the Affordable Care Act, but a majority of the uninsured are still unaware of main components of the law, according to a poll from the Kaiser Family Foundation.
Fast Track for Taiho Oncology's mCRC Molecule
Taiho Oncology, Inc, announced that the FDA granted Fast Track designation for an oral combination anticancer drug under investigation for the treatment of refractory metastatic colorectal cancer.
In the Literature: New Lead in Treating ALL
The paper, published in Nature, has identified a "switch" that can be inhibited to restrict tumor growth.
CDC's New Directive on PPE for Healthcare Workers Treating Ebola Patients
The CDC has released guidelines with detailed information on the type of personal protective equipment and the procedure for donning and removing, for healthcare workers managing Ebola patients.
Patients Are the “Missing Piece” for ACO Success
Industry experts discussed the big issues facing accountable care organizations (ACO) at the Brookings Institute’s event, The State of Accountable Care: Evidence to Date and Next Steps, held Monday in Washington, DC.
Including Panobinostat Improves PFS in Multiple Myeloma
Including panobinostat in a regimen that included bortezomib and dexamethasone improved median PFS to 11.9 months as compared with 8.08 months in the control arm.
A SNP That Affords Protection From Breast Cancer Identified
The study, published in the journal Nature Communications, identified the single nucleotide polymorphism near the coding region of the estrogen receptor ESR1 among Latina women.
Data Collection, Telehealth, and Importance of Primary Care Physicians Get Attention at ACO Coalition Meeting
Attendees at the ACO and Emerging Healthcare Delivery Coalition meeting held October 16-17, 2014, in Miami, Fla., gained insights to help physicians and accountable care organizations achieve the “Triple Aim” of better population health, greater patient satisfaction, and lower costs. This initiative of The American Journal of Managed Care has now attracted more than 120 members.
ONC Interoperability Roadmap Draft Unveils Guiding Principles
The Office of the National Coordinator for Health Information Technology unveiled a draft for its 10-year plan for healthcare interoperability at a joint meeting on October 15.
New Initiative Seeks to Harness Data to Improve Community Health
A new initiative from the Robert Wood Johnson Foundation will explore how health information and data can be used to improve health in the community.
FDA Allows Testing of Ebola Experimental Drug by Chimerix
Brincidofovir is being developed by the company against several different viruses, including smallpox and Ebola.
CMS Issues Draft Coverage Decision For Prostate Cancer Test by GenomeDX
The Decipher test is intended for use in men who have undergone radical prostatectomy and are at a high risk of disease recurrence.
Myriad’s Prostate Cancer Test Receives Draft Medicare Coverage
Myriad Genetics, Inc., announced today that the Medicare Administrative Contractor (MAC) that has jurisdiction over most molecular diagnostic tests has issued its draft notice on how Medicare will provide reimbursement for Prolaris, a test that Myriad has developed to guide treatment decisions in prostate cancer.